Targeting ATR in vivo using the novel inhibitor VE-822 results in selective sensitization of pancreatic tumors to radiation. (Q36525188)
Jump to navigation
Jump to search
scientific article published on 6 December 2012
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Targeting ATR in vivo using the novel inhibitor VE-822 results in selective sensitization of pancreatic tumors to radiation. |
scientific article published on 6 December 2012 |
Statements
Targeting ATR in vivo using the novel inhibitor VE-822 results in selective sensitization of pancreatic tumors to radiation (English)
E Fokas
R Prevo
J R Pollard
P M Reaper
P A Charlton
E M Hammond
M M Olcina
W Gillies McKenna
R J Muschel
6 December 2012
1 reference
1 reference
1 reference